Gene · 7915
Papers818
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 818
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the molecular impact of ALDH5A1 missense variants in succinic semialdehyde dehydrogenase deficiency through combined in vitro and in silico approaches. | Sci Rep | 2026 | 42469357 | PubTator, text mining | PubMed |
| Succinic semialdehyde dehydrogenase deficiency: exploring the relationship between ALDH5A1 variants and molecular effect on SSADH. | Orphanet J Rare Dis | 2026 | 42218553 | PubTator, text mining | PubMed |
| ALDH5A1 as a key in osteonecrosis of the femoral head: Insights from bioinformatics and experimental validation. | Biomed Rep | 2026 | 41930101 | PubTator, text mining | PubMed |
| Postnatal gene restoration in succinic semialdehyde dehydrogenase deficiency (SSADHD) reveals phenotype reversibility. | bioRxiv | 2026 | 41928951 | PubTator, text mining | PubMed |
| Heterogeneity of monogenic epilepsy in loci, phenotypes, and treatment approaches. | Neurol Sci | 2026 | 41912906 | PubTator, text mining | PubMed |
| Proteomics signature of moderate-to-vigorous physical activity and risk of multimorbidity of cancer and cardiometabolic diseases. | Commun Med (Lond) | 2026 | 41826625 | PubTator, text mining | PubMed |
| Selective inhibition of ALDH1A3 impedes breast cancer growth and metastasis by blocking ALDH1A3-driven transcriptional programs. | iScience | 2026 | 41797928 | PubTator, text mining | PubMed |
| Bioinformatics Analysis Reveals ALDH5A1: A Novel Molecular Brake on Th17 Cell Pathogenicity in Systemic Lupus Erythematosus. | FASEB J | 2026 | 41797515 | PubTator, text mining | PubMed |
| Molecular mechanisms in podocytopathies: finding suitable targets for a new era of glomerular gene therapy. | Clin Kidney J | 2026 | 41788620 | PubTator, text mining | PubMed |
| Myoclonus in Pediatric Metabolic Diseases: Clinical Spectrum, Mechanisms, and Treatable Causes-A Systematic Review. | Metabolites | 2026 | 41745581 | PubTator, text mining | PubMed |
| 4,5-dihydroxyhexanoic acid is a robust circulating and urine marker of mitochondrial disease and its severity. | bioRxiv | 2026 | 41727150 | PubTator, text mining | PubMed |
| Prenatal exposure to antiseizure medications and risk of autism spectrum disorder in offspring: an integrated pharmacovigilance and two-sample mendelian randomization study. | Epilepsy Res | 2026 | 41713156 | PubTator, text mining | PubMed |
| Metabolic Stroke: Atypical Presentation of Succinic Semialdehyde Dehydrogenase Deficiency. | JIMD Rep | 2026 | 41631259 | PubTator, text mining | PubMed |
| Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery. | Biomark Res | 2026 | 41527006 | PubTator, text mining | PubMed |
| Bioinformatics-based identification and validation of mitochondria-related genes associated with neonatal sepsis. | PeerJ | 2025 | 41424725 | PubTator, text mining | PubMed |
| Network toxicology and machine learning reveal the toxicological impact of Bisphenol A exposure on osteoarthritis. | Medicine (Baltimore) | 2025 | 41261566 | PubTator, text mining | PubMed |
| Editorial: Autoimmunity: novel insights and future perspectives. | Front Immunol | 2025 | 41246308 | PubTator, text mining | PubMed |
| Exploration of propionate metabolism-related genes to predict prognosis and immunotherapy response in ovarian cancer. | J Ovarian Res | 2025 | 41024209 | PubTator, text mining | PubMed |
| The Role of the ALDH Family in Predicting Prognosis and Therapy Response in Pancreatic Cancer. | Biomedicines | 2025 | 40868269 | PubTator, text mining | PubMed |
| Severe epilepsy phenotypes in adults with succinic semialdehyde dehydrogenase deficiency: Novel clinical and therapeutic insights from an Italian multicenter retrospective cohort study. | Seizure | 2025 | 40763422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7915/papers